SKI Market

Indian Indices

Nifty

24,426.85 -74.05
(-0.30%)

Sensex

79,809.65 -270.92
( -0.34%)

Bank Nifty

53,655.65 -164.70
( -0.31%)

Nifty IT

35,181.25 -307.50
( -0.87%)

Global Indices

Nasdaq

45,566.70 -91.21
(-0.20%)

Dow Jones

6,481.27 -41.59
(-0.64%)

Hang Seng

42,764.54 -64.25
(-0.15%)

Nikkei 225

9,187.34 -29.48
(-0.32%)

Forex

USD-INR

87.60 -0.05
(-0.06%)

EUR-INR

102.16 0.14
(0.13%)

GBP-INR

118.33 0.25
(0.21%)

JPY-INR

0.60 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Novartis India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500672

INE234A01025

317.91821

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NOVARTIND

22.2

2282.05

EPS(TTM)

Face Value()

Div & Yield %

41.63

2.7

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	390.09	366.84	413.52	486.66	453.73	532.69
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	390.09	366.84	413.52	486.66	453.73	532.69
Other Income	41.96	61.68	58.11	33.19	33.09	36.14
Stock Adjustments	-3.75	-9.86	-2.35	9.12	-10.74	-1.83
Total Income	428.30	418.66	469.28	528.97	476.08	567.00
EXPENDITURE :
Raw Materials	199.07	189.98	199.34	187.26	135.88	180.49
Power & Fuel Cost	0.14	0.18	0.35	0.53	0.53	1.27
Employee Cost	18.72	22.96	35.64	101.89	108.51	113.87
Other Manufacturing Expenses	8.18	5.00	12.58	31.15	33.51	36.19
Selling & Administrative Expenses	59.74	65.55	82.78	144.40	128.11	174.87
Miscellaneous Expenses	9.07	8.05	15.40	53.08	9.66	12.14
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	294.92	291.72	346.09	518.31	416.20	518.83
Operating Profit	133.38	126.94	123.19	10.66	59.88	48.17
Interest	0.77	1.49	1.75	4.83	7.68	6.39
Gross Profit	132.61	125.45	121.44	5.83	52.20	41.78
Depreciation	2.19	2.61	6.06	9.65	12.16	13.14
Profit Before Tax	130.42	122.84	115.38	-3.82	40.04	28.64
Tax	29.96	37.63	1.68	-0.44	22.62	15.22
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.44	0.02	10.34	0.34	-3.48	3.34
Reported Net Profit	100.90	85.19	103.36	-3.72	20.90	10.08
Extraordinary Items	0.08	1.99	0.17	-44.68	0.03	-0.01
Adjusted Net Profit	100.82	83.20	103.19	40.96	20.87	10.09
Adjustment below Net Profit	0.97	1.21	3.11	8.19	-6.09	-24.81
P & L Balance brought forward	728.84	759.72	677.94	698.16	708.04	747.46
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	61.73	117.28	24.69	24.69	24.69	24.69
P & L Balance carried down	768.98	728.84	759.72	677.94	698.16	708.04
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	500.00	500.00	950.00	200.00	200.00	200.00
Dividend Per Share(Rs)	25.00	25.00	47.50	10.00	10.00	10.00
Earnings Per Share-Unit Curr	40.88	34.52	41.88	-1.51	8.47	4.08
Earnings Per Share(Adj)-Unit Curr	40.88	34.52	41.88	-1.51	8.47	4.08
Book Value-Unit Curr	318.06	301.79	314.29	280.27	288.16	292.03
Book Value(Adj)-Unit Curr	318.06	301.79	314.29	280.27	288.16	292.03

24,426.85 -74.05 (-0.30%)

79,809.65 -270.92 ( -0.34%)

53,655.65 -164.70 ( -0.31%)

35,181.25 -307.50 ( -0.87%)

45,566.70 -91.21 (-0.20%)

6,481.27 -41.59 (-0.64%)

42,764.54 -64.25 (-0.15%)

9,187.34 -29.48 (-0.32%)

87.60 -0.05 (-0.06%)

102.16 0.14 (0.13%)

118.33 0.25 (0.21%)

0.60 0.00 (0.24%)